HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy and tolerability of cefixime in otitis media. A multicentre study in over 25,000 children.

Abstract
A large scale multicentre clinical study was undertaken to assess the efficacy and tolerability of cefixime in the treatment of acute otitis media in children. A total of 25,863 evaluable children with acute otitis media received cefixime 8 mg/kg once daily for at least 10 days. At the end of treatment, 86% of patients were considered to be either cured or improved. These results are consistent with those achieved with cefixime in controlled clinical trials. Adverse effects were reported in 11.5% of patients, but were judged to be related to cefixime therapy in only 9.4% of patients. The results of this study demonstrate that cefixime is an effective and well tolerated treatment for acute otitis media in children.
AuthorsD H Wu
JournalDrugs (Drugs) Vol. 42 Suppl 4 Pg. 30-2 ( 1991) ISSN: 0012-6667 [Print] New Zealand
PMID1725152 (Publication Type: Clinical Trial, Journal Article, Multicenter Study)
Chemical References
  • Cefixime
  • Cefotaxime
Topics
  • Acute Disease
  • Cefixime
  • Cefotaxime (analogs & derivatives, therapeutic use)
  • Child
  • Child, Preschool
  • Drug Tolerance
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Otitis Media (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: